NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » MC10and AbbVie announce clinical trials in multiple sclerosis using the BioStamp nPoint system » 16May – AbbVie

MC10and AbbVie announce clinical trials in multiple sclerosis using the BioStamp nPoint system

NS Medical Devices is using cookies

Image: MC10 and AbbVie collaborate for clinical trials in multiple sclerosis. Photo: Courtesy of AbbVie Inc.

Related Article

How the remote treatment of hypertension could become a standard of care in the near future

RECOMMENDED COMPANIES

MOST READ

How the remote treatment of hypertension could become a standard of care in the near future

Robotic laparoscopy: Is it the future of minimally-invasive surgical procedures?

Scientists create synthetic cell with patterns of division like natural bacteria

What to expect as MD&M and BIOMEDevice join forces for two-day virtual event

Therapeutic bed equal to parental comfort in managing pain in pre-term babies in the NICU

Recommended Whitepaper